Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Dalian Medical UniversityActive in the last 2 years

Changmiao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2466-5990; OpenAlex author ID A5063406130. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: 2 papers

Papers 4

  1. FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Last author DOI 10.1007/s12013-024-01653-7↗
  2. Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Last author DOI 10.1007/s12013-025-01710-9↗
  3. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrin… Last author DOI 10.3389/fendo.2023.1127441↗
  4. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microe… Last author DOI 10.3389/fendo.2023.1153909↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Wei Jiang · 3 shared papers, 2023–2025 · strength 0.64
  2. Zhuo Yang · 2 shared papers, 2025 · strength 0.46
  3. Jiangning Gu · 2 shared papers, 2025 · strength 0.46
  4. Yougang Cui · 2 shared papers, 2023 · strength 0.36
  5. Ning Li · 2 shared papers, 2023 · strength 0.36
  6. Qihang Yuan · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.